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Introduction  
A spreading annual herb of waste places; introduced in 
habitat of waste places of Flora of Howrah. Plant is her-
baceous, not woody and round. The large leaves are up 
to 8 inches long and are heart-shaped (cordate). The leaf 
blade's basal lobes are rounded. Leaf veins radiate from 
a single point. The leaves have long stems (petioles), 
and are alternate on the stem. flowers are small, yellow-
ish and fragrant, hanging in relatively long clusters 
(panicles and spikes) up to 4 inches long. Plants produce 
"aerial part of the plant" that are attached closely to the 
stems where leaves attach to the stem (axil). They are 
grayish and somewhat irregular.  
Compilation Kallstroemia pubescens 
• Kallstroemia pubescens. 
• Kallstroemia maxima. 
• Tribulus pubescens. 
• Kallstroemia longipes. 
• Tribulus maximus. 
• Kallstroemia minor. 
Morphology 
Flower: In axillary spikes, small. Flowering starts from 
September-November. 
Fruit: Oblong. 
Field tips: Stem twining to the left. Leaves are 7-13 
nerved from base. 
Leaf Arrangement: Opposite 
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Leaf Type: Simple 
Leaf Shape: Ovate-suborbicular 
Leaf Apex: Acuminate-shortly caudate 
Leaf Base: Base is Cordate 
Leaf Margin: leaves are Entire 
 
Fig 1. Aerial part of Kallstroemia pubescens 
General Habitat: Moist deciduous in the forests ie flo-
ra of Howrah, Indian distribution. 
Diosgenin (25R-spriost-5-en-3β-ol) is a hydrolysate of 
dioscin contained in the rootstock 
of yam and it exists widely in the natural plant such as 
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ABSTRACT 
Diosgenin is an aglycone of the steroidal saponin, dioscin in yam and is a principal raw material for the industrial pro-
duction of steroid drugs. It belongs to triterpene group and is of great interest to the pharmaceutical industry because 
of its estrogenic effect on the mammary gland. It plays an important role in cholesterol metabolism and it is responsi-
ble for morphological and biochemical changes in megakaryocyte cells. Diosgenin is an important steroidal metabo-
lite used as a starting material for the synthesis of steroidal drugs, as it exhibits estrogenic activity. Work concluded 
that diosgenin possess therapeutic actions such as anti-inflammatory, anticancer. Its anti-inflammatory activity is 
mainly due to COX activity. Diosgenin is reported to stabilize lysosomal membrane and causes uncoupling of oxida-
tive phosphorylation and having strong oxygen radical scavenging activity. 
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glucoside [1]. The discovery of diosgenin 
in the tubers of the yield yam has made it one of the 
most researched and studied herbal product. 
Many health benefits are associated with diosgenin, for 
example, prevention against cardiovascular disease, 
cancer and contraception [2, 3]. Diosgenin is an im-
portant steroidal metabolite used as a starting material 
for the synthesis of steroidal drugs, as it exhibits estro-
genicactivity [4]. Diosgenin has indicated effect of re-
ducing the level of serum cholesterol [5, 6]. It is mainly 
used as the initial material for partial synthesis of oral 
contraceptives, sex hormones and other steroids. Dios-
genin has received considerable attention because of the 
variety of them promising pharmaceutical properties [7, 
8,9]. The consumption of diosgenin has positive actions 
on stress and inflammatory conditions. 
Collection of Specimens  
The different organs of this plant were cut and removed 
from the plant and fixed in FAA (Formalin 5ml + Ace-
tic acid 5ml + 70 % Ethyl alcohol 90 ml) for histologi-
cal studies, transverse sections of the different organs of 
the plant materials. After 24 hours of fixing, the speci-
mens were dehydrated with graded series of tertiary 
butyl alcohol (TBA) as per the schedule given by sass, 
1940. Infiltration of the specimens was carried out by 
gradual addition of paraffin wax until TBA solution 
attained super saturation. The specimens were cast into 
paraffin blocks.  
Sectioning  
The paraffin embedded specimens were section with the 
help of rotator microtome. The thicknesses of the sec-
tion were 10-12 um. Dewaxing of the sections was per-
formed by customary procedure (Johansen et al). The 
sections were stained with toludine blue as according to 
the method prescribed by O Brien et al. Wherever nec-
essary, the sections were also stained with saffranin and 
fast –green. The microphotographs of the sections were 
made using Olympus BX 40 microscope attached with 
Olympus DP12 digital camera.  
Physico-chemical Standards  
Physico-chemical constants such as consistency and 
organoleptic characters and the percentage of total ash, 
acid-insoluble ash, water-soluble ash and extractive 
values and loss on drying (LOD) were calculated as per 
the Indian Pharmacopoeia (Anonymous, et al).  
Phytochemical Screening of KP Extracted with Dif-
ferent Solvents  
The extracts were tested for the presence of alkaloids, 
flavonoids, glycosides, phenols, resins, saponins, tan-
nins, volatile oils, carbohydrates and amino acids using 
standard procedure.   
Plant extraction 
Five hundred grams of powdered of aerial parts of Kall-
stroemia pubescens were macerated separately in a 2 L 
flask using redistilled methanol as solvent for a period 
of 72 h with intermittent stirring with a glass rod and 
filtered using filter paper (Whatman No. 1, Whatman® 
Schleicher and Schuell). The combined filtrates were 
concentrated using Rotavapor (Rotavapor R-210; Buchi 
Rotavapor) at a temperature of 40°C under reduced 
pressure. The extracts were stored at 4°C until needed 
for analysis. 
Test organisms 
Liver flukes (Fasciola gigantica, 2.2 to 4.4 cm in length) 
were obtained from freshly slaughtered cattle in the 
Bodija abbatoir, in Ibadan metropolis (7.40°N, 3.92°E). 
Earthworms (Pheritima posthuma, 5.5 to 12.5 cm in 
length) were collected from the water logged areas of 
Chhatarpur, M.P. It was used due to its anatomical and 
physiological resemblance with parasitic gastrointestinal 
nematodes in human being). 
Anthelmintic bioassay: The anthelmintic study of the 
flesh and peel extracts against the selected worms (P. 
posthuma and F. gigantica) was conducted according to 
the method described by Ajaiyeoba et al. with slight 
modifications. Plant extract (10 g) was dissolved in sa-
line water to make stock solution and different concen-
trations of (100, 70, 50, 20 and 10 mg/ml) were pre-
pared for the anthelmintic assay. Albendazole (10 mg/
ml) was included as reference drug, while saline water 
was included as control. Standard drug and extract solu-
tions were freshly prepared before starting the experi-
ment. For the evaluation of each plant extract, five 
worms (same type) were placed in a 9 cm Petri dish 
containing 25 ml solution of methanol crude extracts of 
plant in the tested concentrations. The plant extract was 
dispensed into the Petri-dish before introducing the 
worms. Observations were made for the time taken until 
paralysis and death of an individual worm. Mean time 
for paralysis (P in min) was taken when no movement 
of any sort could be observed, except when the worms 
were shaken vigorously. Times of death of worms (D in 
min) were recorded after ascertaining that worms nei-
ther moved when shaken rigorously nor when dipped in 
warm water (50°C). The LC50 was determined using a 
linear regression. 
Epidemiologic Studies: Diosgenin has been used in 
traditional Chinese medicine for treatment of urethral 
and renal infections [10]. Diosgenin, made by hydroly-
sis of saponins, which were extracted from Kallstroemia 
pubescens, a plant which grows in India, shows pre-
sumed ability to minimize post-menopausal symptoms 
[11]. In Turkey, diosgenin is used as a good antispas-
modic, that it can be used for cramps, coughs and for 
muscular spasms [12]. A new Indian source for diosgen-
in is Costus speciosus, which is used to induce apoptosis 
in cancer cells and to reduce high blood pressure [13]. 
Diosgenin extracted from Trigonella foenum graecum 
commonly called fenugreek, is a leguminous plant na-
tive to many Asian, Middle eastern & European coun-
tries, and is used as a hypoglycemic agent in type I and 
type II diabetes [14]. Over the past decade a series of 
preclinical & mechanistic studies have been conducted 
worldwide to understand the role of diosgenin as a 
chemopreventive agent against several cancers. 
Experimental studies: Diosgenin plays an important 
role in the cholesterol metabolism Roman et.al, fraction-
ated the liver using diosgenin to elevate biliary choles-
terol and found that diosgenin can be absorbed through 
gut. A lot of experiments had been conducted to show 
that Diosgenin significantly induce apoptosis in various 
cell lines. Sahelian et al, studied the effects of sustained 
delivery of diosgenin on the adrenal gland of female rats 
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[15]. The changes in body weight, organ weight and 
histopathological changes in the adrenal gland of rats 
were observed and it shows that reduction in adrenal 
mass may pose a potential for major endocrine compli-
cations. Zhony Yao Za Zhi investigated the antitumor 
activity of diosgenin in vivo and invitro. Tumor growth 
inhibit rates were calculated. He showed that diosgenin 
has an obvious antitumor activity on S-180, Hep A, U14 
transplant mice in vivo and L 929, Hela, MCF cells 
invitro [16]. 
Extraction of diosgenin: Methods of extraction of di-
osgenin from Kallstroemia pubescens, CH Wright in-
clude direct acid hydrolysis, spontaneous fermentation, 
supercritical CO2 extraction and so on. 
Recently, some researchers used a single enzyme such 
as cellulose, the amylase combined with 
acid hydrolysis to treat drug material, demonstrating 
that about 70% diosgenin can be extracted from the ma-
terial [17-20]. However, the activity of enzyme gradual-
ly reduces owing to the change of catalysis environ-
ment, so that the catalysis efficiency of enzyme will also 
reduce. Therefore, it is urgent to find efficient methods 
to enhance the stability of natural cellulase. Current 
methods that enhance the stability of natural cellulose 
include selection, protein engineering, enzyme immobi-
lization, enzyme chemical modification and adding a co
-solvent agent [21]. 
Production of Diosgenin: Kallstroemia pubescens is 
the dominant resource for the production of diosgenin. 
They were more than 1500t of diosgenin are produced 
annually. Kallstroemia pubescens cells aggregates were 
cultured in liquid modified MS medium supplemented 
with 2,4-D(2mg/l) and kinetine(0.1 mg/l). The cells 
were treated with different concentrations of ethylene-
generating agent 2-chloroethylphosphonic acid (2-
CEPA). 2-CEPA at concentrations of 50 mg/l, 100 mg/l 
elicited production of diosgenin [22, 23]. 
Diosgenin-Quantification: The diosgenin concentra-
tions in a Kallstroemia pubescens tuber collection from 
EC, India were determined by HPLC and their percent-
ages ranged from 0.02 to 2.64%. The average of dios-
genin, recovery was 97%. Diosgenin was identified by 
gas chromatography-mass spectrometry (GC-MS) and 
coelution with authentic diosgenin standard in both 
HPLC and GCMS techniques. It shows that Kallstroe-
mia pubescens is a potential new source of diosgenin
[24]. 
Bioactive Compounds derived from Diosgenin: By 
utilizing the intact skeleton of diosgenin, OSW-1 and its 
analogues were synthesized.Its anticancer activities are 
10-100 times more powerful than some of the well 
known anticancer agents currently in clinical use, such 
as mitomycin C, adriamycin and taxol [25]. From readi-
ly available diosgenin, 16β-hydroxy-5α-cholestane-3,6-
dione, a metabolite from marine algae was synthesized. 
It is a potent oxysterol, which exhibit a number of bio-
logical activities, including inhibition of cellular prolif-
eration and cytotoxicity associated with induction of 
apoptosis [26] 
Certonardosterol D2, a polyhydroxysterol was stereose-
lectively synthesized from natural rich diosgenin, which 
possess a potent antitumor activity [27] 
Regulation of Diosgenin Expression: Regulation of 
the diosgenin expression in Kallstroemia pubescens 
plants by different plant growth regulators was studied. 
Treatment with 10-5 and 10-4 M gibberelic acid led to 
43% and 19% increases, respectively of diosgenin in 30
-day-old whole plants. These increases might be associ-
ated with the action that this growth regulator has in 
stimulating plant growth and the biosynthetic pathway 
of this sapogenin. A similar increase was obtained with 
the 10-5M indole-3-acetic acid treatment. Treatment 
with 50 ppm ethepon increased the diosgenin levels 
observed in the leaves of 15 and 30-day-old plants, 
growth of the whole plant being substantially reduced at 
30 days in comparison with the growth observed in con-
trol plants [28]. 
Dose: The amount of diosgenin to be administered per 
day is in the range 100 to 2000 mg, preferably 150 to 
1200 mg, most preferably 300 to 1200 mg. This amount 
may be administered in a single dose or in more than 
one dose which may be taken at different times through-
out the day. 
Pharmacological properties of Diosgenin 
Hypoglycemic activity: Consumption of commercial 
diosgenin demonstrated hypoglycemic properties, which 
are beneficial in diabetes by reducing intestinal disac-
charides activities. It has been reported using experi-
mental studies in diabetic male wistar rats, where there 
is a significant increase in lactase and maltase activities, 
reduced intestinal sucrose activity. The activity of glu-
cose -6- phosphate was significantly increased [29]. 
Hypolipidemic and Antioxidant Activity: Oxidative 
stress has been suggested as a main risk factor in the 
development of atherosclerosis. Diosgenin enhanced the 
resistance to lymphocyte DNA damage caused by an 
oxidant challenge with H2O2.The hypolipidemic and 
antioxidative effect on rats fed with a high cholesterol 
diet supplemented with either 0.1% or 0.5% diosgenin 
for 6 weeks has been investigated. Diosgenin showed a 
decrease in the plasma and hepatic total cholesterol lev-
els [30]. 
Neuroprotective Activity: Human Immuno deficiency 
virus (HIV) infection continues to rise in drug-abusing 
populations and causes a dementing illness in a subset 
of individuals. In-vitro studies showed that HIV pro-
teins, gp120 and Tat,Tat + morphine caused increased 
neurotoxicity in human neuronal cultures with ApoE4 
allele. A number of novel antioxidants has been 
screened and found that only L-deprenyl and diosgenin 
protected against the neurotoxicity of Tat + morphine 
[31]. 
Vasodilating Activity: Diosgenin is structurally “fairly 
similar” to progesterone. It is the precursor for the in-
dustrial large scale synthesis of different hormones in-
cluding progesterone and norethisterone. The vasodilat-
ing effect of diosgenin was studied and it shows an 
acute, endothelium independent coronary artery relaxa-
tion [32]. 
Role in Cholesterol Metabolism: Diosgenin, structur-
ally similar to cholesterol, has been shown to decrease 
cholesterol absorption and to increase biliary cholesterol 
secretion without altering either serum cholesterol or 
total biliary bile salt secretion [33]. It has been reported 
that increased biliary secretion of cholesterol and lipid 
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vesicles induced by diosgenin, has cytoprotective ef-
fects in the rat liver subjected to obstructive cholestasis 
[34]. 
Role in Melanogenesis: An increased level of melanin 
is characteristic of a large number of skin disease, in-
cluding acquired hyperpigmentation conditions such as 
melasma, post inflammatory melanoderma and solar 
lentigo. Diosgenin inhibits the melanin content signifi-
cantly [35]. Skin aging is a consequence of both pro-
grammed aging that occurs with time and aging caused 
by environmental factors such as exposure to ultraviolet 
rays. The supplementation of natural or synthetic dios-
genin has anti-aging approaches  [36]. 
Role of Diosgenin in Cell Cycle Arrest and Apoptosis 
in Cancer Cell Lines 
Treatment of tumor cells with cytotoxic agents usually 
results in the breakdown of the cell cycle machinery, the 
cells subsequently entering into programmed cell death 
or apoptosis. Diosgenin plays a significant role in apop-
tosis. Diosgenin can inhibit proliferation via blocking 
cell cycle progression at the G2/M phase and subse-
quently progression to apoptosis in human leukemia 
K562 cells. Diosgenin can effectively inhibit the viabil-
ity and proliferation of breast cancer cells MCF-7 [37]. 
Diosgenin induces differentiation of human erythroleu-
kemia cell line (HEL TIB 180) through changing lipox-
ygenase activities. It also has been reported to induce 
apoptosis and cell cycle arrest in human osteosarcoma 
1547 cell line. Diosgenin induced Hela cell apoptosis 
through caspase pathway [38]. Cyclooxygenase (COXs) 
are key enzymes in the conversion of arachidonic acid 
into prostanoids which are involved in apoptosis and 
inflammation. Two distinct COXs have been identified, 
COX-1 which is constitutively expressed and COX-2 
which is induced by different products such as tumor 
promoter or growth factors. Diosgenin, induces apopto-
sis and its effects were tested on COX expression and 
activity in osteosarcoma cells [39].  
Rheumatoid arthritis: RA is an inflammatory joint 
disease in which perpetuation of chronic synovitis leads 
to bone and cartilage degradation. Diosgenin causes an 
inhibition of the growth of fibroblast like synoviocytes 
from human rheumatoid arthritis, with apoptosis induc-
tion associated with cyclooxygenase-2 up-regulation 
[40]. Colon cancer is considered a preventable disease. 
However, there seems to be no decline in the incidence 
of colon cancer and many of the risk factors associated 
with colon cancer prevail. In-vitro experiments indicat-
ed that diosgenin inhibits cell growth and induces apop-
tosis in the HT-29 human colon cancer cell line in a 
dose dependent manner [41]. Fatty acid synthase (FAS) 
expression is markedly elevated in HER 2-
overexpressing breast cancer cells. In this, diosgenin 
found to be effective in suppressing FAS expression in 
HER 2-overexpressing breast cancer cells and preferen-
tially inhibited proliferation and induced apoptosis in 
HER 2-overexpressing cancer cells [42]. 
Adverse Effect: As an herbal extract, diosgenin appears 
to be free of any major adverse effects. In this, diosgen-
in found to be effective in suppressing FAS expression 
in HER 2-overexpressing breast cancer cells and prefer-
entially inhibited proliferation and induced apoptosis in 
HER 2-overexpressing cancer cells. 
Drug also shows sustained delivery of diosgenin on the 
adrenal gland of female rats [43] 
Conclusion   
Large number of studies have revealed that diosgenin 
possess therapeutic actions such as anti-inflammatory, 
anticancer. Its anti-inflammatory activity is mainly due 
to COX activity. Diosgenin is reported to stabilize lyso-
somal membrane and causes uncoupling of oxidative 
phosphorylation and having strong oxygen radical scav-
enging activity. Most interesting feature of diosgenin is 
lack of intestinal side effects, thus it is used in the syn-
thesis of oral contraceptives, sex hormones. More recent 
work is needed in order to explore its new areas of ap-
plication. 
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